Investor Fact Sheet

Island Pharmaceuticals Limited

Business Description:
Island Pharmaceuticals (ASX:ILA) is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections.

Island Pharmaceuticals Limited (ILA) was listed on the Australian Stock Exchange on 13 April 2021
Island Pharmaceuticals was incorporated on 25 May 2020.

Shares on Issue:
113,796,642 ordinary shares and 32,507,388 Options with Piggy Back Right, as at 16 April 2024.

Australian Securities Exchange (ASX code: ILA)

Registered Office:
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

Principal Place of Business:
Suite 201
697 Burke Road
Camberwell, Victoria 3124


Managing Director:
Dr David Foster

Joint Company Secretaries:
Cameron Jones
Stephanie Vipond

Dr. Paul MacLeman - Executive Chairman
Dr. David Foster - Managing Director - CEO
Dr. David Brookes - Non Executive Director
Mr. Albert Hansen - Non Executive Director
Dr. Anna Lavelle - Non Executive Director

Chief Financial Officer
Mr Cameron Jones

Grant Thornton

Share Registry:
Automic Registry Services
Level 5, 126 Phillip Street, Sydney, Nsw, Australia, 2000

1300 288 664 (within Australia)
+61 2 9698 5414 (outside Australia)
Facsimile: +61 2 8583 3040